​

Relmada Therapeutics Ownership | Who Owns Relmada Therapeutics?

OverviewForecastFinancialsChartTranscripts

Relmada Therapeutics Ownership Summary

Relmada Therapeutics is owned by 116.90% institutional investors, 2.86% insiders. Janus henderson group is the largest institutional shareholder, holding 28.02% of RLMD shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.02% of its assets in Relmada Therapeutics shares.

RLMD Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockRelmada Therapeutics116.90%2.86%-19.76%
SectorHealthcare Stocks 50.53%12.40%37.07%
IndustryBiotech Stocks 48.96%12.12%38.92%
IdeaPsychedelic Stocks List37.36%7.72%54.92%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Janus henderson group11.06M28.02%$76.89M
Blackrock funding, inc. /de7.43M8.58%$51.39M
Vr adviser6.84M7.90%$47.36M
Adage capital partners gp4.76M5.50%$32.96M
Vanguard capital management4.46M5.15%$30.86M
Orbimed advisors3.63M4.19%$25.13M
Vanguard group1.20M3.63%$5.81M
State street2.52M2.91%$17.42M
Geode capital management2.49M2.88%$17.25M
Millennium management2.36M2.73%$16.34M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Stempoint capital lp1.46M1.74%$10.10M
Knott david m jr451.00K1.65%$3.12M
Ikarian capital2.15M1.60%$14.87M
Vr adviser6.84M1.44%$47.36M
Birchview capital, lp408.10K1.32%$2.82M
Sio capital management1.00M1.15%$6.94M
Great point partners842.11K1.10%$5.83M
Highvista strategies445.80K0.70%$3.08M
Commodore capital lp1.43M0.59%$9.86M
Opaleye management935.00K0.59%$6.47M

Top Buyers

HolderShares% AssetsChange
Blackrock funding, inc. /de7.43M0.00%6.14M
Janus henderson group11.06M0.04%3.79M
State street2.52M0.00%2.16M
Vr adviser6.84M1.44%2.00M
Geode capital management2.49M0.00%1.64M

Top Sellers

HolderShares% AssetsChange
Ra capital management---2.95M
Marshall wace, llp2.25M0.01%-2.23M
Braidwell lp---1.58M
Millennium management2.36M0.01%-1.55M
Orbimed advisors3.63M0.47%-1.08M

New Positions

HolderShares% AssetsChangeValue
Walleye capital616.24K0.02%616.24K$4.26M
Highvista strategies445.80K0.70%445.80K$3.08M
Harvest investment services340.89K0.36%340.89K$2.36M
Bank of new york mellon295.62K0.00%295.62K$2.05M
Sixth street partners management company282.72K0.00%282.72K$1.96M

Sold Out

HolderChange
Blackston financial advisory group-2.00
Innealta capital-5.00
Smartleaf asset management-35.00
Larson financial group-100.00
Golden state equity partners-200.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202613020.37%101,233,65619.49%1161.22%8532.81%21-12.50%
Mar 31, 202636-57.14%7,826,692-84.63%190.08%20-63.64%6-45.45%
Dec 31, 202543-4.44%13,954,17380.30%427.73%2237.50%8-27.27%
Sep 30, 202544-8.33%7,739,57845.94%239.13%16-5.88%10-23.08%
Jun 30, 2025476.82%5,303,149-14.73%153.82%1741.67%12-14.29%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv3.17M3.02%989.50K
Vanguard Morn Total Stk Mkt Idx Investor3.17M3.02%989.50K
Vanguard MStar Total Stk Mkt Idx Invest3.17M2.97%-
Vanguard US Total Market Shares ETF851.92K2.57%-
iShares Russell 2000 ETF2.38M2.23%-42.34K
Biotech Growth Ord1.49M1.42%-525.17K
Franklin Biotechnology Discv A(acc)USD1.46M1.37%1.46M
Polar Capital Biotech S Inc1.27M1.21%-
Vanguard Institutional Extnd Mkt Idx Tr1.21M1.13%2.13K
Eventide Healthcare & Life Sciences I842.11K0.80%842.11K

Recent Insider Transactions

DateNameRoleActivityValue
Dec 15, 2025TRAVERSA SERGIO Chief Executive OfficerBuy$113.30K
Dec 15, 2025Shenouda Maged Chief Financial OfficerBuy$48.06K
Nov 05, 2025Shenouda Maged Chief Financial OfficerBuy$1.10M
Nov 05, 2025Ence Chuck CAO and COOBuy$299.20K
Nov 05, 2025TRAVERSA SERGIO Chief Executive OfficerBuy$599.50K

Insider Transactions Trends

DateBuySell
2025 Q46-
2025 Q33-
2025 Q28-
2024 Q4--
2024 Q38-

RLMD Ownership FAQ

Who Owns Relmada Therapeutics?

Relmada Therapeutics shareholders are primarily institutional investors at 116.90%, followed by 2.86% insiders and -19.76% retail investors. The average institutional ownership in Relmada Therapeutics's industry, Biotech Stocks , is 48.96%, which Relmada Therapeutics exceeds.

Who owns the most shares of Relmada Therapeutics?

Relmada Therapeutics’s largest shareholders are Janus henderson group (11.06M shares, 28.02%), Blackrock funding, inc. /de (7.43M shares, 8.58%), and Vr adviser (6.84M shares, 7.90%). Together, they hold 44.50% of Relmada Therapeutics’s total shares outstanding.

Does Blackrock own Relmada Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Relmada Therapeutics.

Who is Relmada Therapeutics’s biggest shareholder by percentage of total assets invested?

Stempoint capital lp is Relmada Therapeutics’s biggest shareholder by percentage of total assets invested, with 1.74% of its assets in 1.46M Relmada Therapeutics shares, valued at 10.1M$.

Who is the top mutual fund holder of Relmada Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Relmada Therapeutics shares, with 3.02% of its total shares outstanding invested in 3.17M Relmada Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools